RecruitingPhase 3NCT06200181
Effect of Olanzapine on Opioid Craving and Misuse Among Patients Receiving Opioids for Cancer-related Pain: A Pilot Double-Blind, Randomized Control Trial
Sponsor
M.D. Anderson Cancer Center
Enrollment
87 participants
Start Date
Apr 2, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
To learn about the effectiveness of taking the antipsychotic medication olanzapine to help lower opioid craving.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a drug called Olanzapine, a drug called Olanzapine, and others for people with misuse, opioid. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGOlanzapine
Given by PO
DRUGOlanzapine
Given by PO
DRUGPlacebo
Given by PO
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06200181